Martin J Everett
9PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Jan 20, 2023
Chemical Optimization of Selective <i>Pseudomonas aeruginosa</i> LasB Elastase Inhibitors and Their Impact on LasB-Mediated Activation of IL-1β in Cellular and Animal Infection Models.Martin J Everett, David T Davies, Simon Leiris
|Apr 06, 2021
Novel Specific Metallo-β-Lactamase Inhibitor ANT2681 Restores Meropenem Activity to Clinically Effective Levels against NDM-Positive <i>Enterobacterales</i>.Magdalena Zalacain, Clarisse Lozano, Agustina Llanos
|Mar 31, 2021
Designing Inhibitors of β-Lactamase Enzymes to Overcome Carbapenem Resistance in Gram-Negative Bacteria.David T Davies, Martin Everett
|Dec 11, 2020
Discovery of <b>ANT3310</b>, a Novel Broad-Spectrum Serine β-Lactamase Inhibitor of the Diazabicyclooctane Class, Which Strongly Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacterales and <i>Acinetobacter baumannii</i>.David T Davies, Simon Leiris, Magdalena Zalacain
|Nov 24, 2020
Reply to Asempa et al., "The Ongoing Challenge with NDM-Harboring <i>Enterobacteriaceae</i> in Murine Infection Models".Shampa Das, Martin Everett, Magdalena Zalacain
|Aug 14, 2020
ANT2681: SAR Studies Leading to the Identification of a Metallo-β-lactamase Inhibitor with Potential for Clinical Use in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing <i>Enterobacteriaceae</i>.David T Davies, Simon Leiris, Nicolas Sprynski
Pageof 2
Frequent Collaborators
5 joint publications
David T Davies
4 joint publications
Marc Lemonnier
3 joint publications
Jérôme M Castandet
3 joint publications
Thomas David Pallin
3 joint publications
Jean-Denis Docquier
3 joint publications
Ramesh Pattipati
3 joint publications
Stefano Mangani
3 joint publications
Srinivasu Pothukanuri
3 joint publications
Manuela Benvenuti
3 joint publications
Cecilia Pozzi
